Physician profile
Amanda Raines
NPI 1700264793
$2,250.79
in general payments reported to CMS, 2019-2025
12 companies · $1,413 in 2025
The $1,413 reported for 2025 was more than what 93% of Pediatric Urology providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $221 · 2021: $116 · 2023: $46.13 · 2024: $192 · 2025: $1,413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,001 · Food and Beverage: $564 · Education: $86.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,000.70 |
| Food and Beverage | $563.69 |
| Education | $86.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,338.89 | 2024-2025 | Deflux Metal Needle, Urolift, Deflux |
| Boston Scientific Corporation | $294.93 | 2019-2021 | |
| Astellas Pharma US INC | $164.14 | 2020-2021 | |
| Intuitive Surgical, INC. | $103.06 | 2019-2024 | |
| 180 Medical, INC. | $96.04 | 2025 | |
| Coloplast Corp | $83.33 | 2025 | |
| Palette Life Sciences, INC. | $46.13 | 2023 | |
| Genzyme Corporation | $31.62 | 2019-2020 | |
| Olympus America INC. | $26.74 | 2020 | |
| Urogen Pharma, INC. | $23.04 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.18 | 2021 | |
| Clarus Therapeutics INC. | $20.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Raines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.